Latest Market Research Report 2025

  The global  infectious disease molecular diagnostics market  size is expected to reach USD 59.0 billion by 2030, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 3.9% from 2024 to 2030. The market is estimated to expand at a CAGR of 3.0% from 2020 to 2028. The market is driven by the introduction of technologically advanced products and an increase in demand for molecular diagnostics in PoC settings.   Rapid technological advancements with portability, accurate results, and cost-effectiveness are anticipated to serve as crucial drivers of the market for infectious disease molecular diagnostics. Companies are upgrading their products by implementing new techniques to gain specific and accurate results. Key players are updating their product portfolio for PCR instruments with increased R&D initiatives for developing novel kits to target emerging diseases or by entering into agreements with other ...

  Infectious Disease Molecular Diagnostics Industry Overview The global  infectious disease molecular diagnostics market  size is expected to reach USD 40.8 billion by 2028, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 3.0% from 2020 to 2028. The market is driven by the introduction of technologically advanced products and an increase in demand for molecular diagnostics in PoC settings.   Infectious Disease Molecular Diagnostics Market Segmentation Grand View Research has segmented the global infectious disease molecular diagnostics market based on product, end use, technology, application, and region: Based on the Product Insights, the market is segmented into Instruments, Reagents and Services The reagents segment dominated the market for infectious disease molecular diagnostics and accounted for the largest revenue share of 66.7% in 2020 attributable to the introduction and commercialization...